# Dual-Tracer Theranostic PET

> **NCT05680675** · NA · COMPLETED · sponsor: **University of Utah** · enrollment: 50 (actual)

## Conditions studied

- Neuroendocrine Tumors
- Prostate Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Single-Tracer FDG PET/CT Exam
- **DIAGNOSTIC_TEST:** Single-Tracer Cu64-DOTATATE PET/CT Exam
- **DIAGNOSTIC_TEST:** Single-Tracer Ga68-DOTATATE PET/CT Exam
- **DIAGNOSTIC_TEST:** Single-Tracer PSMA PET/CT Exam

## Key facts

- **NCT ID:** NCT05680675
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-08
- **Primary completion:** 2024-06-04
- **Final completion:** 2024-06-04
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2025-02-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05680675

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05680675, "Dual-Tracer Theranostic PET". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05680675. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*